Frequently Asked Questions About Neuropathy
Davis, DC, BCN and Dr. Greg Davis, DC are co-founders Of Essential Neuropathy in Lee’s Summit. They sit down with us to ...
Combining Regenerative Neurotherapy with Traditional Treatments: A Synergistic Approach to Neuropathy
Peripheral neuropathy, a condition affecting millions of people worldwide, can cause chronic pain, numbness, and weakness, ...
Daily3d
Alkem Labs inks pact with Sonnet BioTherapeutics to develop, commercialise drug candidate for diabetic peripheral neuropathy in India
Mumbai: Alkem Laboratories Ltd. has entered into a licensing agreement with US-based Sonnet BioTherapeutics Holdings, Inc to ...
Rutland Herald3d
Sancic: Understanding peripheral neuropathy
Peripheral neuropathy is a complex and often debilitating condition that affects millions of people worldwide. Research estimates around 10% of the general population experiences some form of ...
India Infoline4d
Alkem Partners with Sonnet for Diabetic Neuropathy Drug in India
The drug is expected to offer nerve regeneration, potentially modifying the disease in diabetic peripheral neuropathy ...
The Financial Express4d
Alkem Labs enters into licensing agreement with Sonnet BioTherapeutics for its diabetic peripheral neuropathy drug in India
India is grappling with a substantial burden of diabetes-related complications with diabetic peripheral neuropathy being a ...
Nerve Recovery Max or Nerve Fresh: Which One May Work Best for Real Results?
Affiliate content. Compare Nerve Recovery and Nerve Fresh to find out which supplement is the better choice for nerve health.
Diabetes: Everything You Need to Know, from Symptoms to Treatment
Diabetes is very common. The Centers for Disease Control and Prevention (CDC) notes that 38.4 million people in the United ...
Alkem Laboratories inks licensing agreement with Sonnet
Alkem Laboratories has entered into a licensing agreement with US-based Sonnet BioTherapeutics Holdings, Inc (Sonnet) to develop, manufacture and commercialise the drug candidate SON-080 for the ...
Alkem Labs signs licensing agreement with Sonnet BioTherapeutics
Alkem Laboratories said that it has entered into a licensing agreement with US-based Sonnet BioTherapeutics Holdings, to develop, manufacture and commercialise the drug candidate 'SON-080' for the ...
cnbctv185d
Alkem Labs signs licensing agreement with Sonnet BioTherapeutics to develop diabetic neuropathy treatment
Under the licensing agreement, Alkem will carry out the clinical development of 'SON-080' in India with support from Sonnet ...